Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Trial EndPoint
CRO
One-third of data collected in trials may be unnecessary: study
Trials have been growing more complex, and the number of data points gathered in phase 3 trials grew from 929,203 to 3,560,201 between 2012 and 2020.
Darren Incorvaia
Sep 19, 2025 11:01am
FDA draft recommends all cancer trials collect OS data
Aug 20, 2025 10:59am
Athersys stock plunges 60% after stroke stem cell therapy miss
May 20, 2022 10:26am
Icon to validate PROs as measurement of FDA clinical endpoints
Feb 22, 2017 10:45am
